Abivax Shares On the Move Again As Filing Catches Trader Interest Ahead of June
Abivax SA shares traded higher on Nasdaq Thursday. Traders pointed to renewed interest in the latest SEC filing, while the market watches for late-quarter data on the company’s main ulcerative colitis drug. The French biotech’s American Depositary Shares were last at $124.03, up 3.5%. About 1.65 million shares changed hands. The ADSs moved between $117.23 and $126.37 in the session.